Cell Replacement Therapy Improves Pathological Hallmarks in a Mouse Model of Leukodystrophy Vanishing White Matter
Summary: Stem cell therapy has great prospects for brain white matter disorders, including the genetically determined disorders called leukodystrophies. We focus on the devastating leukodystrophy vanishing white matter (VWM). Patients with VWM show severe disability and early death, and treatment op...
Main Authors: | Stephanie Dooves, Prisca S. Leferink, Sander Krabbenborg, Nicole Breeuwsma, Saskia Bots, Anne E.J. Hillen, Gerbren Jacobs, Marjo S. van der Knaap, Vivi M. Heine |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Stem Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213671119300207 |
Similar Items
-
In vivo targeting of a variant causing vanishing white matter using CRISPR/Cas9
by: Anne E.J. Hillen, et al.
Published: (2022-06-01) -
Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates
by: Daphne H. Schoenmakers, et al.
Published: (2023-08-01) -
Quantitative MRI in leukodystrophies
by: Menno D. Stellingwerff, et al.
Published: (2023-01-01) -
Leukodystrophy with premature ovarian failure: think on vanishing white matter disease (VWMD)
by: Fernando Freua, et al.
Published: (2015-01-01) -
Recognizing early MRI signs (or their absence) is crucial in diagnosing metachromatic leukodystrophy
by: Daphne H. Schoenmakers, et al.
Published: (2022-12-01)